DIA448.65+3.97 0.89%
SPX6,457.68+11.92 0.18%
IXIC21,700.44+18.54 0.09%

樂普生物-B(2157.HK)暴漲386% 擬進行科創板IPO

樂普生物-B(2157.HK)暴漲386% 擬進行科創板IPO
格隆匯·09/09/2022 07:09:28
Listen to the news
格隆匯9月9日丨樂普生物-B(2157.HK)午後持續拉昇。盤中一度暴漲386.2%報31.8港元,股價創上市新高,暫成交2216萬港元。該股今日已幾度進入市場冷靜調節期階段。消息面上,9月5日,樂普生物-B獲納入港股通標的;9月8日晚,公司發佈公吿稱,擬進行科創板IPO,計劃募資淨額約不超25億元。今年7月,旗下PD-1抗體普特利單抗獲國家藥監局附條件批准上市。
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.